Dr. Alfred Whitfield Forrester, M.D. Psychiatry & Neurology - Psychiatry Medicare: Not Enrolled in Medicare Practice Location: 9515 Deereco Rd, Suite 1001, Timonium, MD 21093 Phone: 410-453-0901 Fax: 410-453-0904 |
Dr. Neil Howard Blumberg, M.D. Psychiatry & Neurology - Forensic Psychiatry Medicare: Not Enrolled in Medicare Practice Location: 30 E Padonia Rd, Suite 206, Timonium, MD 21093 Phone: 410-561-1156 Fax: 410-683-0332 |
Dr. Lois Marie Conn, M.D. Psychiatry & Neurology - Psychiatry Medicare: Not Enrolled in Medicare Practice Location: 16 Pebble Ln, Timonium, MD 21093 Phone: 410-561-1160 Fax: 410-561-5598 |
Supriya Narang, M.D. Psychiatry & Neurology - Psychiatry Medicare: Accepting Medicare Assignments Practice Location: 1925 Greenspring Dr, Timonium, MD 21093 Phone: 410-453-9553 Fax: 410-453-9552 |
Munachim Ifeoma Uyanwune, MD Psychiatry & Neurology - Psychiatry Medicare: Accepting Medicare Assignments Practice Location: 57 W Timonium Rd Ste 305, Timonium, MD 21093 Phone: 443-275-2068 Fax: 410-705-0074 |
Dr. Ayanna Cooke-chen, MD, PHD Psychiatry & Neurology - Psychiatry Medicare: Not Enrolled in Medicare Practice Location: 57 W Timonium Rd, Suite 215, Timonium, MD 21093 Phone: 443-546-5350 |
News Archive
In this Washington Post opinion piece, Bill Gates, co-founder of the Bill & Melinda Gates Foundation, cites declines in global child mortality rates as an example of how development aid works, and writes, "I am giving a report Thursday to the heads of the Group of 20 (G20) governments, including President Obama, suggesting creative ways for the world to continue investing in development despite fiscal constraints."
Older adults are at risk for both impaired oral health and malnutrition, according to a study by Rutgers University researchers.
Researchers from Kaiser Permanente's Northern California region are presenting a study at this week's American Heart Association Scientific Sessions showing that patients who use a generic statin drug rather than its brand-name equivalent fared as well as- sometimes better than-patients on the more expensive drug.
The Biomarkers Consortium, a unique public-private partnership that includes the U.S. Food and Drug Administration (FDA), the National Institutes of Health (NIH), and major pharmaceutical companies, led by the Foundation for the National Institutes of Health (FNIH), today announced the launch of a highly anticipated clinical trial to help screen promising new drugs being developed for women with high risk, fast-growing breast cancers—women for whom an improvement over standard treatment could dramatically change the odds of survival.
› Verified 7 days ago